Viking Therapeutics Inc (NASDAQ: VKTX): At Current Prices, Does It Make Sense To Wait?

Viking Therapeutics Inc (NASDAQ:VKTX)’s traded shares stood at 0.72 million during the latest session, with the company’s beta value hitting 1.17. At the last check today, the stock’s price was $65.05, to imply a decrease of -2.14% or -$1.42 in intraday trading. The VKTX share’s 52-week high remains $99.41, putting it -52.82% down since that peak but still an impressive 87.27% since price per share fell to its 52-week low of $8.28. The company has a valuation of $7.11B, with an average of 6.46 million shares over the past 3 months.

Viking Therapeutics Inc (NASDAQ:VKTX) trade information

After registering a -2.14% downside in the latest session, Viking Therapeutics Inc (VKTX) has traded red over the past five days. The stock hit a weekly high of 70.81, dropping -2.14% in its intraday price action. The 5-day price performance for the stock is -8.21%, and -0.20% over 30 days. With these gigs, the year-to-date price performance is 249.53%.

Viking Therapeutics Inc (VKTX) estimates and forecasts

Looking at statistics comparing Viking Therapeutics Inc share performance against respective industry, we note that the company has underperformed competitors. Viking Therapeutics Inc (VKTX) shares are 506.79% up over the last 6 months, with its year-to-date growth rate lower than industry average at -20.88% against 13.10%.

An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -18.89% for the past 5-year period. While 2024 is set for a -23.49% return in earnings, projections for the next 5 years are at 40.00% annually.

VKTX Dividends

Viking Therapeutics Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Viking Therapeutics Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.